Annotation Detail

Information
Associated Genes
PTEN
Associated Variants
PTEN DELETION ( ENST00000371953.8 )
PTEN DELETION ( ENST00000371953.8 )
Associated Disease
cancer
Source Database
CIViC Evidence
Description
In a single-arm, open label phase 2 trial in PIK3CA amplified/mutated and/or PTEN loss encompassing 10 patients, no objective responses were observed but a stable disease response in 4 patients, resulting in a median PFS of 1.4 months. Everolimus failed to meet its enpoint.
Variant Origin
N/A
Variant Origin
N/A
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/5840
Gene URL
https://civic.genome.wustl.edu/links/genes/41
Variant URL
https://civic.genome.wustl.edu/links/variants/214
Rating
3
Evidence Type
Predictive
Disease
Cancer
Evidence Direction
Does Not Support
Drug
Everolimus
Evidence Level
B
Clinical Significance
Sensitivity/Response
Pubmed
28330462
Drugs
Drug NameSensitivitySupported
EverolimusSensitivityfalse